Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Accumulated Expenses (2017 - 2025)

Neuronetics (STIM) has disclosed Accumulated Expenses for 9 consecutive years, with $9.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses fell 15.54% to $9.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $9.7 million, a 15.54% decrease, with the full-year FY2024 number at $12.8 million, up 5917.84% from a year prior.
  • Accumulated Expenses was $9.7 million for Q3 2025 at Neuronetics, up from $190000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $12.8 million in Q4 2024 to a low of $173000.0 in Q1 2025.
  • A 5-year average of $3.9 million and a median of $822000.0 in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: tumbled 98.1% in 2023, then surged 5917.84% in 2024.
  • Neuronetics' Accumulated Expenses stood at $5.1 million in 2021, then soared by 120.06% to $11.2 million in 2022, then crashed by 98.1% to $213000.0 in 2023, then soared by 5917.84% to $12.8 million in 2024, then dropped by 24.69% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Accumulated Expenses are $9.7 million (Q3 2025), $190000.0 (Q2 2025), and $173000.0 (Q1 2025).